Search

Travis Paul Remarchuk

from San Francisco, CA
Age ~53
Get Report
Also known as:
Travis P Remarchuk, Traivs Remarchuk, Travis K
Phone and address:
201 Harrison St APT 904, San Francisco, CA 94105
Connected to:
Markus Remark, 61Hugh S Remash, 87Sherrill H Remba, 64David B Rembach, 50Nathan R Rembacki, 45Richard K Rembach, 73Justin M Rembe, 34Mary A Rembelski, 80Diane S Rember, 72Audrey D Rembert, 60

Travis Remarchuk Phones & Addresses

  • 201 Harrison St APT 904, San Francisco, CA 94105
  • 2443 Massachusetts Ave, Cambridge, MA 02140 (617) 492-1777
  • 2443 Massachusetts Ave #6, Cambridge, MA 02140 (617) 492-1777
  • 5204 Palo Verde Rd, Irvine, CA 92612 (949) 856-3190
  • San Diego, CA
  • Del Mar, CA

Work

Company: Gordon research conferences Jul 2017 to Jul 2017 Position: 2017 co-chair of organic reactions and processes

Education

School / High School: Harvard University 2003 to 2006 Specialities: Organic Chemistry

Skills

Organic Synthesis • Organic Chemistry • Drug Discovery • Medicinal Chemistry • Chemistry • Small Molecules • Hplc • Chromatography • Biotechnology • Drug Development • Pharmaceutical Industry • Life Sciences • Nmr • Drug Design • Purification • Lc Ms • Public Speaking • Technical Presentations • Publications

Emails

t***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Travis Remarchuk Photo 1

South San Francisco, California

View page
Location:
South San Francisco, CA
Industry:
Pharmaceuticals
Work:
Gordon Research Conferences Jul 2017 - Jul 2017
2017 Co-Chair of Organic Reactions and Processes
Genentech Jul 2006 - Mar 2016
Scientist and Senior Scientist, Process Chemistry
Denali Therapeutics Jul 2006 - Mar 2016
Staff Scientist Cmc
Harvard University 2003 - 2006
Postdoc With Professor Ej Corey
Agouron Pharmaceuticals 1995 - 1998
Research Associate, Process Chemistry
Education:
Harvard University 2003 - 2006
Uc Irvine 1998 - 2003
Doctorates, Doctor of Philosophy, Organic Chemistry University of Saskatchewan 1989 - 1994
Bachelors, Bachelor of Science, Organic Chemistry
Skills:
Organic Synthesis
Organic Chemistry
Drug Discovery
Medicinal Chemistry
Chemistry
Small Molecules
Hplc
Chromatography
Biotechnology
Drug Development
Pharmaceutical Industry
Life Sciences
Nmr
Drug Design
Purification
Lc Ms
Public Speaking
Technical Presentations
Publications

Publications

Us Patents

Efficient Synthetic Routes For The Preparation Of Rhinovirus Protease Inhibitors And Key Intermediates

View page
US Patent:
6355807, Mar 12, 2002
Filed:
Aug 23, 2000
Appl. No.:
09/643864
Inventors:
Qingping Tian - San Diego CA
Naresh K. Nayyar - San Diego CA
Srinivasan Babu - San Diego CA
Junhua Tao - San Diego CA
Terence Jarold Moran - San Diego CA
Raymond Dagnino, Jr. - El Cajon CA
Travis Paul Remarchuk - Irvine CA
Michael Joseph Melnick - Ann Arbor MI
Steven Lee Bender - Oceanside CA
Assignee:
Agouron Pharmaceuticals, Inc.
International Classification:
C07D20726
US Classification:
548248, 548550
Abstract:
Efficient synthetic routes for the preparation of rhinovirus protease inhibitors of formula I, as well as key intermediates useful in those synthetic routes. These compounds of formula I, as well as pharmaceutical compositions that contain these compounds, are suitable for treating patients or hosts infected with one or more picornaviruses.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
6392067, May 21, 2002
Filed:
May 21, 2001
Appl. No.:
09/859368
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
Japan Tobacco Inc. - Osaka
International Classification:
C07C24704
US Classification:
552 10, 549 34
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
6465661, Oct 15, 2002
Filed:
Mar 21, 2002
Appl. No.:
10/101858
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - La Jolla CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - San Diego CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
International Classification:
C07D20902
US Classification:
548473, 558 47
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Efficient Synthetic Routes For The Preparation Of Rhinovirus Protease Inhibitors And Key Intermediates

View page
US Patent:
6774243, Aug 10, 2004
Filed:
Oct 30, 2001
Appl. No.:
09/984555
Inventors:
Qingping Tian - San Diego CA
Naresh K. Nayyar - San Diego CA
Srinivasan Babu - San Diego CA
Junhua Tao - San Diego CA
Terence Jarold Moran - San Diego CA
Raymond Dagnino, Jr. - El Cajon CA
Travis Paul Remarchuk - Irvine CA
Michael Joseph Melnick - Ann Arbor MI
Steven Lee Bender - Oceanside CA
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D20726
US Classification:
548550, 558369, 560169
Abstract:
Efficient synthetic routes for the preparation of rhinovirus protease inhibitors of formula I, as well as key intermediates useful in those synthetic routes. These compounds of formula I, as well as pharmaceutical compositions that contain these compounds, are suitable for treating patients or hosts infected with one or more picornaviruses.

Efficient Methods For The Preparation Of Rhinovirus Protease Inhibitors, Key Intermediates And A Continuous Membrane Reactor Useful For Preparing The Same

View page
US Patent:
20030064429, Apr 3, 2003
Filed:
Jul 25, 2002
Appl. No.:
10/201944
Inventors:
Junhua Tao - San Diego CA, US
Srinivasan Babu - San Diego CA, US
Raymond Dagnino - El Cajon CA, US
Qingping Tian - San Diego CA, US
Travis Remarchuk - Irvine CA, US
Kevin McGee - San Diego CA, US
Naresh Nayyar - San Diego CA, US
Terence Moran - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc.
International Classification:
C12P033/02
C12N009/48
C12N009/50
US Classification:
435/061000, 435/212000, 435/219000
Abstract:
Efficient synthetic routes for the preparation of rhinovirus protease inhibitors of formula I, key intermediates useful in those synthetic routes, as well as a continuous membrane reactor useful for those synthetic routes. These compounds of formula I, as well as pharmaceutical compositions that contain these compounds, are suitable for treating patients or hosts infected with one or more picornaviruses.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
63166259, Nov 13, 2001
Filed:
Jul 21, 2000
Appl. No.:
9/621681
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
Japan Tobacco Inc. - Tokyo
International Classification:
C07D21706
A61K 3147
US Classification:
546146
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Methods Of Making Hiv-Protease Inhibitors And Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
6117999, Sep 12, 2000
Filed:
Feb 19, 1999
Appl. No.:
9/252802
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - Irvine CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Phramaceuticals, Inc. - La Jolla CA
Japan Tobacco, Inc. - Tokyo
International Classification:
C07D21716
US Classification:
546146
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.

Intermediates For Making Hiv-Protease Inhibitors

View page
US Patent:
60841079, Jul 4, 2000
Filed:
Sep 5, 1997
Appl. No.:
8/923942
Inventors:
Srinivasan Babu - San Diego CA
Bennett C. Borer - San Diego CA
Travis P. Remarchuk - San Diego CA
Robert J. Szendroi - San Diego CA
Kathleen R. Whitten - San Diego CA
Juliette K. Busse - Solana Beach CA
Kim F. Albizati - San Diego CA
Assignee:
Agouron Pharmaceuticals, Inc. - La Jolla CA
International Classification:
C07D20936
C07D32704
C07D30502
US Classification:
548485
Abstract:
HIV protease inhibitors inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds can be prepared by the novel methods of the present invention using the novel inventive intermediates.
Control profile
Travis Paul Remarchuk from San Francisco, CA, age ~53 Get Report